Press Releases
Samsung Biologics Participates in the virtual American Biomanufacturing Summit (7/21~23)
AMERICAN BIOMANUFACTURING SUMMIT 2020
WEBINAR SESSIONKey Considerations When Outsourcing an Aseptic Fill/Finish Project to a CMO Partner
July 21, 12:30 ~ 13:05 EST
David King - Director, Drug Product Operations
Samsung Biologics is participating in the American Biomanufacturing Summit, which will be held virtually from 21st to 23rd of July. Throughout the three-day summit, delegates, speakers, and sponsors will be able to gain insights, opportunities, and best practices in driving the biomanufacturing industry forward.
There will be one speaker from Samsung Biologics this year. On July 21st at 12:30-1:05 P.M. EST, our Drug Product Operations Director David King will hold a session on 'Quality and Compliance' to discuss key considerations when outsourcing an aseptic fill/finish project to a CMO partner.
To learn more about our session, please visit here.
AMERICAN BIOMANUFACTURING SUMMIT 2020
WEBINAR SESSIONKey Considerations When Outsourcing an Aseptic Fill/Finish Project to a CMO Partner
July 21, 12:30 ~ 13:05 EST
David King - Director, Drug Product Operations
Samsung Biologics is participating in the American Biomanufacturing Summit, which will be held virtually from 21st to 23rd of July. Throughout the three-day summit, delegates, speakers, and sponsors will be able to gain insights, opportunities, and best practices in driving the biomanufacturing industry forward.
There will be one speaker from Samsung Biologics this year. On July 21st at 12:30-1:05 P.M. EST, our Drug Product Operations Director David King will hold a session on 'Quality and Compliance' to discuss key considerations when outsourcing an aseptic fill/finish project to a CMO partner.
To learn more about our session, please visit here.